Usage(Amicar) is FDA-approved for use in the treatment of acute bleeding due to elevated fibrinolytic activity. It also carries an Orphan Drug designation from the FDA for the prevention of recurrent hemorrhage in patients with traumatic hyphema.
(Amicar) is FDA-approved for use in the treatment of acute bleeding due to elevated fibrinolytic activity. It also carries an Orphan Drug designation from the FDA for the prevention of recurrent hemorrhage in patients with traumatic hyphema.
99%
C6H13NO2
Amicarthiazol Trade Information
Cash in Advance (CID) Cash Advance (CA)
500 Kilograms KG Per Month
2-8 Week
Yes
Sample costs shipping and taxes has to be paid by the buyer
Carton and Poly Bag.
Western Europe Australia Eastern Europe Middle East Central America Africa South America Asia North America